Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.

Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and funct...

Full description

Bibliographic Details
Main Authors: Michel Fausther, Elise G Lavoie, Jonathan A Dranoff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5595315?pdf=render
_version_ 1819021487173009408
author Michel Fausther
Elise G Lavoie
Jonathan A Dranoff
author_facet Michel Fausther
Elise G Lavoie
Jonathan A Dranoff
author_sort Michel Fausther
collection DOAJ
description Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgαV and Pdgfrβ, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.
first_indexed 2024-12-21T04:07:53Z
format Article
id doaj.art-1847ef9a821946539777935b464233a1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T04:07:53Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1847ef9a821946539777935b464233a12022-12-21T19:16:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018449910.1371/journal.pone.0184499Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.Michel FaustherElise G LavoieJonathan A DranoffLiver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgαV and Pdgfrβ, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.http://europepmc.org/articles/PMC5595315?pdf=render
spellingShingle Michel Fausther
Elise G Lavoie
Jonathan A Dranoff
Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
PLoS ONE
title Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
title_full Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
title_fullStr Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
title_full_unstemmed Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
title_short Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.
title_sort liver myofibroblasts of murine origins express mesothelin identification of novel rat mesothelin splice variants
url http://europepmc.org/articles/PMC5595315?pdf=render
work_keys_str_mv AT michelfausther livermyofibroblastsofmurineoriginsexpressmesothelinidentificationofnovelratmesothelinsplicevariants
AT eliseglavoie livermyofibroblastsofmurineoriginsexpressmesothelinidentificationofnovelratmesothelinsplicevariants
AT jonathanadranoff livermyofibroblastsofmurineoriginsexpressmesothelinidentificationofnovelratmesothelinsplicevariants